Image

Patients Treated in Real Life With VEnetoclax for WAldenström Macroglobulinemia

Participating in a study using VEnetoclax for Waldenström Macroglobulinemia.

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

Waldenström Macroglobulinemia (WM) is a type of blood cancer that's hard to cure. Venetoclax is a medicine already used to treat other types of blood cancers, like Chronic Lymphocytic Leukemia (CLL) and Acute Myeloid Leukemia. This medicine works by blocking a protein called BCL2 that helps cancer cells survive. In a study with 32 WM patients, 84% responded to Venetoclax treatment, which means their cancer got better. Our study wants to see how well Venetoclax works for WM patients in France and how well they tolerate it. This study looks back at patients who have already been treated. If you have WM and have been treated with Venetoclax, you might fit the study's criteria.

  • This study looks at past treatments and does not involve new medication trials.
  • There is no risk from participating since it's based on past treatments.
  • No extra visits or procedures are needed as it reviews existing medical records.
Print
Study details
    Waldenstrom's Macroglobulinaemia Refractory

NCT06200220

Poitiers University Hospital

24 January 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.